Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 3.61M P/E - EPS this Y 32.10% Ern Qtrly Grth -
Income -26.16M Forward P/E -0.43 EPS next Y 97.20% 50D Avg Chg -14.00%
Sales 3.07M PEG - EPS past 5Y - 200D Avg Chg -67.00%
Dividend N/A Price/Book 0.35 EPS next 5Y - 52W High Chg -96.00%
Recommedations 3.00 Quick Ratio 0.06 Shares Outstanding 10.01M 52W Low Chg 10.00%
Insider Own 0.42% ROA -44.91% Shares Float 9.97M Beta -0.79
Inst Own 2.68% ROE -314.92% Shares Shorted/Prior 39.52K/23.70K Price 0.59
Gross Margin -250.95% Profit Margin - Avg. Volume 129,282 Target Price -
Oper. Margin -510.09% Earnings Date Mar 28 Volume 48,502 Change -3.31%
About OpGen, Inc.

OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artificial intelligence powered bioinformatics solutions for antibiotic response prediction; and Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers. It also utilizes molecular diagnostics and informatics to help combat infectious diseases. The company helps clinicians with information about life threatening infections to enhance patient outcomes, and to decrease the spread of infections caused by multidrug-resistant microorganisms. OpGen, Inc. has a collaboration with the New York State Department of Health and ILÚM Health Solutions, LLC to develop a research program to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Rockville, Maryland.

OpGen, Inc. News
03/25/24 OpGen Announces Acquisition of Preferred Stock by David Lazar
11/14/23 OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update
10/12/23 OpGen Enters Into Warrant Inducement Transaction for up to $11.2 Million in Gross Proceeds
10/12/23 ChatGPT Parent OpenAI Aims At Budget-Friendly AI Innovations, Novo Nordisk's Popular Diabetes Drug Ozempic Faces Counterfeit Threat in Germany: Today's Top Stories
08/13/23 OpGen, Inc. (NASDAQ:OPGN) Q2 2023 Earnings Call Transcript
08/11/23 Q2 2023 OpGen Inc Earnings Call
08/10/23 OpGen Reports Second Quarter 2023 Financial Results and Provides Business Update
08/07/23 OpGen’s Subsidiary Ares Genetics Releases New Features to its AREScloud Offering
08/03/23 OpGen’s Subsidiary Curetis and FIND Extend R&D Collaboration Agreement
08/03/23 OpGen to Provide Business Update and Financial Results for the Second Quarter 2023 on August 10th at 4:30 p.m. Eastern Time
07/19/23 OpGen’s Subsidiary Curetis Meets Milestones of Extended and Expanded R&D Collaboration with FIND
06/26/23 OpGen Subsidiary Ares Genetics Successfully Maintains Key Patent under Opposition in Europe
06/22/23 OpGen’s Subsidiary Curetis Receives Batch of Ten New C-Series Unyvero A30 Instruments
06/20/23 OpGen Presents Unyvero Urinary Tract Infection Panel Trial Results at ASM Microbe 2023 Conference
05/16/23 Q1 2023 OpGen Inc Earnings Call
05/15/23 OpGen Reports First Quarter 2023 Financial Results and Provides Business Update
05/08/23 OpGen to Provide Business Update and Financial Results for the First Quarter 2023 on May 15th at 4:30 p.m. Eastern Time
05/04/23 OpGen Announces Closing of $3.5 Million Public Offering
05/01/23 OpGen Announces Pricing of $3.5 Million Public Offering
04/26/23 OpGen’s Subsidiary Curetis Meets All Remaining Key Milestones in R&D Collaboration with FIND
OPGN Chatroom

User Image trf07 Posted - 33 minutes ago

@MonitoringCoin weren't you shorting $OPGN somedays before?

User Image leeeboy Posted - 36 minutes ago

$OPGN We rich yet? 🤪⬆💥

User Image BiotechnicallyRetarded Posted - 5 hours ago

$GMDA praying for all the gang who got burned here. If anyone wants to gamble the pittance they have left check out $OPGN or $SLS both are primed for a moonshot. If not I understand and hope you all can recover losses asap

User Image theDipState Posted - 6 hours ago

$OPGN I guess we are a SPAC play now. 😂 A special purpose acquisition company (SPAC; /spæk/), also known as a "blank check company", is a shell corporation listed on a stock exchange with the purpose of acquiring (or merging with) a private company, thus making the private company public without going through the initial public offering process, which often carries significant procedural and regulatory burdens

User Image theDipState Posted - 6 hours ago

$OPGN Very sick to my stomach but I’m now thinking Ollie and his band of idiots are going to have Curetis back in their possession and running it privately.

User Image theDipState Posted - 7 hours ago

$OPGN All you need to know. He’s going to use OpGen’s shell and merge it with a private company to get them listed . No idea how this is going to play out guys. 🤷‍♂️ OpGen could be selling Swiss chocolates soon or mining crypto.

User Image WeakSauceOut Posted - 7 hours ago

$OPGN Arguing with a fool will make you a fool, my bull friends.

User Image MonitoringCoin Posted - 8 hours ago

$OPGN CoinRaider says we're all too dumb to know what just happened to us...

User Image MonitoringCoin Posted - 9 hours ago

$OPGN Wut, don't get so frazzled...just Nucleate.

User Image MonitoringCoin Posted - 9 hours ago

$OPGN Check out Souf, aka Wut, still monitoring each post. -Ivy League fancy pants has nothing better to do? Claims to never have held or shorted, but enjoys protecting naive retail...my ass. Good thing you had that ex-OPGN employee feeding you all that inside info so you could pawn it off as omniscience. Just waiting for Coin, Gunther, and the rest of the Bashers to chime in. I knew if I threw some chum out, they'd find it irresistible.

User Image MonitoringCoin Posted - 9 hours ago

$OPGN Someone please clarify this "The conversion of the Series E Preferred Stock into shares of common stock in excess of applicable statutory and regulatory thresholds, including national stock exchange rules, will be subject to receipt of stockholder approval for the issuance of such shares of Common Stock." Barring some loophole, proposed dilution in Lazar's favor would be subject to vote. Is everyone just going to vote yes without a sweetener? I don't think so...

User Image ChartHawk Posted - 10 hours ago

$OPGN Sometimes we get very caught up in the technical aspects of a trade, and forget about the scientific value, and it's marketability. ie: Antibiotic overuse is about to become a Pandemic. What is the value of the remedy, and the predictive AI inherit here in $OPGN Plus UTI, and the epidemiology. 50- 70% of women have UTI's some time in their life, and 30% of those are recurring. Technically, and fundamentally undervalued, especially considering D. Lazar's 13M investment, 200M in research & FDA in the cue, (we are trading @ 6.8M).

User Image MrHustleBaby Posted - 11 hours ago

$OPGN Nobody wants to sell here because Lazar doesn’t mess around, look at $MINM. Stock has been consistently moving up. We all know this will squeeze well past $1. News is coming soon. I’m buying any weakness in the meantime and this technical setup could lead to a squeeze on its own 🤑

User Image Dragonslayer2065 Posted - 12 hours ago

$OPGN Does everyone know there is a gap at .55. That's where I have my buy of 500,000 shares

User Image BowernTrumpl Posted - 12 hours ago

$OPGN our pos hold up well !!

User Image WeakSauceOut Posted - 12 hours ago

$OPGN Solid day, my bull friends.

User Image Mrshades619 Posted - 12 hours ago

$OPGN she is so ready to pop 💥💥💥💥💥💥💣💎💎💎💎

User Image ChartHawk Posted - 13 hours ago

$OPGN We may have traded sideways all day, but Williams is hugging top line on the chart; significant accumulation. Can't imagine anyone selling down here, except Day Traders. De Novo was submitted at the beginning of April 23. The language of our PR this week indicated that there are strategic things happening based on contingencies. I imagine FDA? Anyone? Also, don't you think if Ares was sold, we will be getting shares of "something", or a divi? Anyone have any idea what's coming? Please advise! Valuation is 7M. Lazar shell out almost twice as much coin for his nut? HOLD & load dips

User Image Mrshades619 Posted - 13 hours ago

$OPGN im ready 🤑💎🤑💎💥

User Image ChartHawk Posted - 13 hours ago

$OPGN .75 break is squeeze on daily; also should start the retrace on the 100 c&h. We are pulled back on the handle for the load.

User Image AmarinAllDay Posted - 13 hours ago

$OPGN

User Image Blunter_Hiden Posted - 14 hours ago

$OPGN squeeze imminent

User Image leeeboy Posted - 14 hours ago

$OPGN

User Image MrHustleBaby Posted - 14 hours ago

$OPGN Traders are locked and loaded, a 5 cent move up and radars start flashing. A 10 cent move up and this will squeeze! Lets prime that engine 🚀🤑

User Image BigDaddyBoss Posted - 14 hours ago

$OPGN ⬆️ ⬆️ ⬆️

User Image MrHustleBaby Posted - 14 hours ago

$OPGN Heavyweight is getting worried, posts are getting more desperate must be a sign the bull flag is about to launch 🚀🤑

User Image HeavyweightUndercover Posted - 14 hours ago

$OPGN the difference between today and yesterday is 75M volume. Will only implode deeper.

User Image HeavyweightUndercover Posted - 14 hours ago

$OPGN .69

User Image StockMET Posted - 15 hours ago

$OPGN bull flag 🚩 don’t sleep on it $1 next

User Image WiganWarrior Posted - 15 hours ago

$OPGN Going through my base line again, should see this go through 0.73 this time

Analyst Ratings
HC Wainwright & Co. Neutral Aug 14, 23
HC Wainwright & Co. Buy Jul 20, 23
HC Wainwright & Co. Buy Jun 26, 23
HC Wainwright & Co. Buy Jun 21, 23
HC Wainwright & Co. Buy May 16, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Bacher Johannes Chief Operating Offi.. Chief Operating Officer Mar 02 Option 0.00 21,250 81,250 03/04/22
Schacht Oliver Chief Executive Offi.. Chief Executive Officer Mar 02 Option 0.00 38,750 68,750 03/04/22
Bacher Johannes Chief Operating Offi.. Chief Operating Officer Jan 26 Buy 0.85 25,000 21,250 60,000 01/27/22